Equities analysts expect Intuitive Surgical, Inc. (NASDAQ:ISRG) to post sales of $765.97 million for the current quarter, according to Zacks. Five analysts have issued estimates for Intuitive Surgical’s earnings. The lowest sales estimate is $754.00 million and the highest is $791.60 million. Intuitive Surgical posted sales of $674.20 million during the same quarter last year, which suggests a positive year-over-year growth rate of 13.6%. The business is expected to announce its next earnings results on Tuesday, April 17th.
On average, analysts expect that Intuitive Surgical will report full-year sales of $765.97 million for the current fiscal year, with estimates ranging from $3.45 billion to $3.53 billion. For the next year, analysts forecast that the firm will report sales of $3.90 billion per share, with estimates ranging from $3.68 billion to $4.03 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of analysts that cover Intuitive Surgical.
Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, January 25th. The medical equipment provider reported $2.54 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.27 by $0.27. The business had revenue of $892.40 million for the quarter, compared to analyst estimates of $866.54 million. Intuitive Surgical had a net margin of 21.09% and a return on equity of 19.93%. The business’s quarterly revenue was up 17.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.03 EPS.
Several equities analysts recently weighed in on ISRG shares. Zacks Investment Research upgraded shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating and set a $437.00 target price on the stock in a report on Tuesday, December 12th. ValuEngine lowered shares of Intuitive Surgical from a “hold” rating to a “sell” rating in a report on Friday, December 29th. Goldman Sachs Group restated a “buy” rating on shares of Intuitive Surgical in a report on Saturday, November 18th. Morgan Stanley lifted their target price on shares of Intuitive Surgical from $450.00 to $500.00 and gave the company an “overweight” rating in a report on Friday, January 26th. Finally, BidaskClub lowered shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a report on Tuesday, December 12th. One analyst has rated the stock with a sell rating, six have issued a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $408.48.
Intuitive Surgical (NASDAQ:ISRG) traded up $7.72 during trading hours on Friday, hitting $427.51. 469,468 shares of the company traded hands, compared to its average volume of 960,406. The firm has a market cap of $48,010.00, a price-to-earnings ratio of 50.18, a price-to-earnings-growth ratio of 4.96 and a beta of 0.50. Intuitive Surgical has a 1-year low of $242.26 and a 1-year high of $452.00.
In other Intuitive Surgical news, EVP Curet Myriam sold 262 shares of the business’s stock in a transaction on Tuesday, January 30th. The shares were sold at an average price of $431.50, for a total value of $113,053.00. Following the transaction, the executive vice president now owns 2,152 shares in the company, valued at approximately $928,588. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Gary S. Guthart sold 28,525 shares of the business’s stock in a transaction on Monday, February 5th. The stock was sold at an average price of $414.50, for a total transaction of $11,823,612.50. Following the completion of the transaction, the chief executive officer now owns 311,469 shares in the company, valued at approximately $129,103,900.50. The disclosure for this sale can be found here. Insiders sold a total of 85,877 shares of company stock worth $35,631,764 in the last quarter. 2.20% of the stock is currently owned by company insiders.
Institutional investors have recently modified their holdings of the company. First Trust Advisors LP raised its stake in shares of Intuitive Surgical by 61.4% in the 3rd quarter. First Trust Advisors LP now owns 51,130 shares of the medical equipment provider’s stock valued at $53,476,000 after purchasing an additional 19,458 shares in the last quarter. Davis R M Inc. acquired a new stake in shares of Intuitive Surgical in the 3rd quarter valued at about $219,000. Point72 Asset Management L.P. acquired a new stake in shares of Intuitive Surgical in the 3rd quarter valued at about $24,264,000. Chevy Chase Trust Holdings Inc. raised its stake in shares of Intuitive Surgical by 206.2% in the 4th quarter. Chevy Chase Trust Holdings Inc. now owns 179,792 shares of the medical equipment provider’s stock valued at $65,613,000 after purchasing an additional 121,082 shares in the last quarter. Finally, Bender Robert & Associates raised its stake in shares of Intuitive Surgical by 188.2% in the 3rd quarter. Bender Robert & Associates now owns 38,308 shares of the medical equipment provider’s stock valued at $13,355,000 after purchasing an additional 25,015 shares in the last quarter. Institutional investors and hedge funds own 61.59% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This news story was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The correct version of this news story can be accessed at https://www.dispatchtribunal.com/2018/02/24/intuitive-surgical-inc-isrg-expected-to-announce-quarterly-sales-of-765-97-million.html.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Get a free copy of the Zacks research report on Intuitive Surgical (ISRG)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.